GPT and metabolic dysfunction-associated steatotic liver disease: The liver damage markers including ALT (61.20 ± 110.41) and AST (61.20 ± 110.41) were significantly elevated in NAFLD normal weight subjects, while ALT and AST were in the normal range in overweight and obese subjects.